参考文献:1. Rigamonti, D, Drayer, BP, Johnson, PC, Hadley, MN, Zabramski, J, Spetzler, RF (1987) The MRI appearance of cavernous malformations (angiomas). J Neurosurg 67: pp. 518-524 CrossRef 2. Otten, P, Pizzolato, GP, Rilliet, B, Berney, J (1989) 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 35: pp. 82-83 3. Labauge, P, Denier, C, Bergametti, F, Tournier-Lasserve, E (2007) Genetics of cavernous angiomas. Lancet Neurol 6: pp. 237-244 CrossRef 4. Rigamonti, D, Hadley, MN, Drayer, BP, Johnson, PC, Hoenig-Rigamonti, K, Knight, JT, Spetzler, RF (1988) Cerebral cavernous malformations. Incidence and familial occurence. N Engl J Med 319: pp. 343-347 CrossRef 5. Pagenstecher, A, Stahl, S, Sure, U, Felbor, U (2009) A two-hit mechanism causes cerebral cavernous malformation: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18: pp. 911-918 6. Sahoo, T, Johnson, EW, Thomas, JW, Kuehl, PM, Jones, TL, Dokken, CG, Touchman, JW, Gallione, CJ, Lee-Lin, SQ, Kosofsky, B, Kurth, JH, Louis, DN, Mettler, G, Morrison, L, Gil-Nagel, A, Rich, SS, Zabramski, JM, Boguski, MS, Green, ED, Marchuk, DA (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8: pp. 2325-2333 CrossRef 7. Fischer, A, Zalvide, J, Faurobert, E, Albiges-Rizo, C, Tournier-Lasserve, E (2013) Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med 19: pp. 302-308 CrossRef 8. Gault, J, Sain, S, Hu, LJ, Awad, IA (2006) Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery 59: pp. 1278-1284 CrossRef 9. Batra, S, Lin, D, Recinos, PF, Zhang, J, Rigamonti, D (2001) Cavernous malformations; natural history, diagnosis and treatment. Nat Rev Neurol 5: pp. 659-670 CrossRef 10. Gross, BA, Lin, N, Du, R, Day, AL (2011) The natural history of intracranial cavernous malformations. Neurosurg Focus 30: pp. E24 CrossRef 11. Denier, C, Labauge, P, Brunereau, L, Cavé-Riant, F, Marchelli, F, Arnoult, M, Cecillon, M, Maciazek, J, Joutel, A, Tournier-Lasserve, E (2004) Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 55: pp. 213-220 CrossRef 12. Grippaudo, FR, Piane, M, Amoroso, M, Longo, B, Penco, S, Chessa, L, Giubettini, M, Santanelli, F (2013) Cutaneous venous malformations related to KRIT1 mutation: case report and literature review. J Mol Neurosci 51: pp. 442-445 CrossRef 13. Sirvente, J, Enjolras, O, Wassef, M, Tournier-Lasserve, E, Labauge, P (2009) Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol 23: pp. 1066-1072 CrossRef 14. Acosta, FL, Sanai, N, Chi, JH, Dowd, CF, Chin, C, Tihan, T, Chou, D, Weinstein, PR, Ames, CP (2008) Comprehensive management of symptomatic and aggressive vertebral hemangiomas. Neurosurg Clin N Am 19: pp. 17-29 CrossRef 15. Toldo, I, Drigo, P, Mammi, I, Marini, V, Carollo, C (2009) Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation. Surg Neurol 71: pp. 167-171 CrossRef 16. Clatterbuck, RE, Cohen, B, Gailloud, P,
刊物主题:Neurology; Neurochemistry; Neurosurgery;
出版者:BioMed Central
ISSN:1471-2377
文摘
Background Cerebral cavernous malformations are relatively rare vascular disorders that may affect any part of the central nervous system. This presentation has been associated with heterozygous mutations in CCM1/KRIT1, CCM2/malcavernin and CCM3/PDCD10. We aimed to investigate the genetic defect underlying multiple cerebral and vertebral cavernous malformations in a multigenerational Italian family. Case presentation The proband is a 49-year-old man who underwent cerebral MRI in his thirties for persistent haeadache and tingling in his left arm and leg and was diagnosed with multiple supratentorial cavernous angiomas. A right frontal angioma with radiological evidence of a recent bleeding was surgically removed when he was 39?years old and he was thereafter asymptomatic. Magnetic resonance imaging revealed multiple cerebral cavernous malformations in seven members of his familily. Four subjects were asymptomatic. Other family mambers displayed heterogeneous clinical features including seizures and recurrent brain haemorrhages. Sequence analysis in the proband disclosed a novel heterozygous nucleotide substitution (c.263-10A-?G) in intron 5 of CCM1. This variant is predicted to create an abnormal acceptor splice site and segregated in affected relatives available for molecular screening. The analysis of CCM1 transcript in proband’s lymphocytes confirmed the partial retention of intron 3 resulting in a premature termination codon. Conclusions Our findings demonstrate that c.263-10A-?G mutation is associated with cerebral cavernous malformations. A better knowledge of the disease-associated phenotype may lead to an early diagnosis and to an appropriate clinical surveillance in affected patients.